The western green mamba is classified as a snake of medical importance in western SubSaharan Africa by the
World Health Organization, although bites from this species are rare as it is rarely encountered. Similar to the venom of most other mambas, the western green mamba's contains predominantly three-finger toxin agents. The exception is the black mamba, whose venom lacks the potent
alpha-neurotoxin as well. It is thought this may reflect the species' preferred prey—small mammals for the mainly land-dwelling black mamba, versus birds for the other predominantly arboreal mambas. Unlike that of many snake species, the venom of mambas has little
phospholipase A2. Overall, the venom of the western green mamba is more potent than that of the eastern green mamba, similar or slightly less potent than that of Jameson's mamba, and much less potent than that of the black mamba. The venom consists mainly of both pre-synaptic and post-synaptic
neurotoxins,
cardiotoxins, In another test using mice that were administered the western green mamba's venom via the intraperitoneal (IP) route the LD50 was 0.045 mg/kg. Another experimental IV LD50 toxicity of 0.5 mg/kg has been reported, with an average wet venom yield of 100 mg.
Treatment The speed of onset of envenomation means that urgent medical attention is needed.
Tetanus toxoid is sometimes administered, though the main treatment is the administration of the appropriate antivenom. ==Notes==